-
10 trillion won
Time of Update: 2023-01-10
7 billion) by 2025 to accelerate "sustainable growth" in its battery materials business and other business lines South Korea's LG Chem recently said it plans to invest 10 trillion won ($8.
-
The world's population exceeded the 8 billion mark
Time of Update: 2023-01-05
The findings suggest that as recently as 2016, some parts of the bat coronavirus shared a common ancestor with SARS-CoV-2 – just 3 years later, the virus appeared in humans in late 2019.
-
2022 CSH Professor Wang Ying: A new breakthrough in CAR-T therapy, Herkirensai injection is expected to break the bottleneck of r/r B-ALL treatment
Time of Update: 2022-10-01
Figure 2 Immunotherapy mechanismFigure 3 The current approval status of CD19 CAR-T cell productsFigure 4 r/r ALL domestic and foreign guideline treatment recommendationsIn a clinical study (IIT) initiated by previous investigators of Hekylense, 30 adults (≥ 18 years old) patients with B-ALL and 30 children and adolescents (< 18 years old) B-ALL patients received Heckirensee cell therapy.
-
Since the beginning of this year, a large number of multinational pharmaceutical companies have failed clinically in tumor immunotherapy
Time of Update: 2022-09-21
The industry believes that from the above, although the market prospects for tumor immunotherapy drugs brought about by favorable policies and capital increases are becoming more and more broad in recent years, the examples of the failure of new drug research and development of these multinational pharmaceutical companies are constantly warning everyone that even if they go through phase I and phase II clinical trials, they may also encounter challenges in phase III.
-
Two chemical drugs have been approved one after another! The landing of pipeline products of the pharmaceutical company is gradually being cashed
Time of Update: 2022-09-14
On September 6, Tasly announced that jiangsu Diyi, a wholly-owned subsidiary of the company, recently received the "Drug Registration Certificate" approved and issued by the State Drug Administration on bortezomib for injection.
-
【2022 WCLC】Professor Wu Yilong: Dual drive, dual precision
Time of Update: 2022-08-20
At the recently held World Conference on Lung Cancer (WCLC), a number of recent results related to MET amplification/overexpression were announced, including the use of sivotinib + osimertinib combination therapy for EGFR mutation-positive and Results of the Phase II SAVANNAH clinical study in osimertinib-resistant patients .
-
"Head" and other important matters, please pay attention
Time of Update: 2022-04-30
At 48 weeks (third endpoint), the greatest increase in total hair count was found with oral 5 mg/d finasteride, which was significantly more effective than 2% minoxidil .
-
How to open the ceiling of the pharmaceutical equipment industry
Time of Update: 2022-04-15
In recent years, innovative drugs including antibody drugs, cell therapy, and gene drugs have flourished, bringing new development opportunities to the upstream equipment and consumables industries .
-
LINEPHARMA submits abortion drug license application in Japan
Time of Update: 2022-03-10
This drug is considered the international gold standard for medical abortion in early pregnancyi and is included in the World Health Organization (WHO) List of Essential Medicines for Abortion .
-
A text get
Time of Update: 2022-03-08
Studies have shown [6] that for newly diagnosed T2DM patients, CSII and multiple daily insulin injections (MDI) have no significant difference in glycemic control and clinical remission rate of diabetes, but CSII has a lower risk of hypoglycemia and can improve patients quality of life .
-
Better Pharmaceuticals is working hard
Time of Update: 2021-12-26
At present, more than 30 domestic companies have submitted applications for the listing of ticagrelor tablets under the new registration classification, of which 20 have been approved for production and deemed to have been reviewed.
-
The global cumulative number of confirmed cases of new crown reaches 254847065
Time of Update: 2021-12-02
WHO: The global cumulative number of confirmed cases of new crown reaches 254847065 WHO: The global cumulative number of confirmed cases of new crown reaches 254847065 WHO: The glob
-
Roche's new crown oral drug failed phase II clinical progress and how is the clinical progress of the other 4 companies
Time of Update: 2021-11-16
Recently, Roche and Atea Pharmaceuticals announced that their new crown oral drug AT-527 global phase II trial MOONSONG did not meet the primary endpoint .
The clinical failure of Roche/Atea's new crown oral drug is right.
-
Five Vietnamese cuisines are recognized by two major international organizations of record
Time of Update: 2021-11-11
delicacy The first 5 records recognized as the world record in the field of Vietnamese food include: possession of the most attractive noodle and soup noodle dishes in the world; possession of the world’s most typical fish sauce and dishes made with fish sauce; possession The world’s most flower dishes; the world’s most unique wrapped dishes; the world’s most attractive rice noodle pastries .
-
The first subcutaneous injection: Roche's Alzheimer's disease drug received FDA breakthrough therapy designation
Time of Update: 2021-10-22
S. Food and Drug Administration (FDA) as a breakthrough therapy for the treatment of patients with Alzheimer's disease (AD) .
Currently, Roche is conducting two randomized, parallel, placebo-controlled global multi-center phase III key clinical trials of Gantenerumab, GRADUATE 1 and 2.
